To construct a model for classifying isocitrate dehydrogenase (IDH) status in gliomas based on multiparametric MRI, a total of 105 patients of grade II-IV gliomas were obtained with 50 IDH mutant and 55 IDH wildtype [55]. This evidence concerns the gene IDH1 and central nervous system cancer.